A comparison of fluspirilene and trifluoperazine in the treatment of acute schizophrenic psychosis.
D000328:Adult; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D006846:Hydrocarbons, Halogenated / Q000627:therapeutic use; D007958:Leukocyte Count; D008111:Liver Function Tests; D008297:Male; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D012562:Schizophrenia, Disorganized / Q000188:drug therapy; D012563:Schizophrenia, Paranoid / Q000188:drug therapy; D013141:Spiro Compounds / Q000627:therapeutic use*; D014268:Trifluoperazine / Q000009:adverse effects / Q000627:therapeutic use*
D006846:Hydrocarbons, Halogenated; D010880:Piperidines; D010919:Placebos; D013141:Spiro Compounds; D014268:Trifluoperazine